NanoMedTrix LLC

Our mission is to develop and deliver innovative nanoparticles that improve the lives of patients around the world. We are committed to providing the highest quality products and services, and to working with our partners to advance the field of nanotechnology. At NanoMedTrix, multi-pronged efforts are underway to increase manufacturing capacity and improve potential toxicity inherent to systemic therapeutic delivery. NanoMedtrix has reached scaling-up levels for commercial applications, including manufacturing strategies for purities, excluding toxic materials, and ready-to-GMP preparations. Our products have been tested for tumoricidal effects with various drug classes such as taxanes, antineoplastic antibiotics, antimetabolite agents, and anti-angiogenic. NanoMedtrix has, from the start, answered the demand and focused on combining powerful tools to simultaneously monitor and selectively treat a wide range of diseases witheffective drugs and new untrialed drugs. Recently, we developed partnerships with the clinical and commercial sectors. We developed models for bladder cancer in two pre-clinical models (mice and dogs) and are poised to begin investigations and sample preparation (scale up and pharmaceutic preps) for first in human.